この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2011/12/131 分で読めます
Quantitative Summary of the Benefits and Risks of Prescription Drugs: A Literature Review
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the availability of a draft report entitled "Quantitative Summary of the Benefits and Risks of Prescription Drugs: A Literature Review" (literature review report). A literature review was conducted to address a requirement of the Patient Protection and Affordable Care Act (Affordable Care Act). FDA is publishing the literature review report to allow the public to provide comment on the report as it relates to the Affordable Care Act.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →